Document is current
Any future updates will be listed below
-
Authors
Petro-Turnquist, Erika M.
Madapong, Adthakorn
Pekarek, Matthew
Steffen, David https://orcid.org/0000-0002-5166-2296
Weaver, Eric A. https://orcid.org/0000-0002-5029-0662
-
Funding
Funding for this research was provided by:
United States Department of Agriculture | Agricultural Research Service (2020-06448)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI147109, T32AI125207)
- License Information
-
More Information
Article History
Received: 12 September 2024
Accepted: 11 April 2025
First Online: 30 April 2025
Competing interests
: E.A.W. is an inventor of the Epigraph immunogens in this study and has a patent application in progress (Application: 62/734,791; International Application: PCT/US19/52137). Due to patents and pending applications restrictions apply regarding the public availability of sequence information for the reported immunogens. However, unique biologicals and sequence information can be requested at Nutech Ventures, Lincoln, NE (US) by contacting info@nutechventures.org and will be processed as promptly as possible. All other authors declare no competing interests.
